Parkinson's disease in the Western Pacific Region (Q92593925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

review article

1 reference

title

Parkinson's disease in the Western Pacific Region (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

Andrew H Evans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Christine Klein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Nobutaka Hattori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Shen-Yang Lim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ai Huey Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Azlina Ahmad-Annuar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Louis C S Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Raymond L Rosales

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Roongroj Bhidayasiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Yih-Ru Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Hui-Fang Shang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Pramod K Pal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Chong Tin Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Beomseok Jeon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Eng-King Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Anthony E Lang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

publication date

4 June 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

865-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

30 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

1 reference

7 January 2021

Treatment gaps in Parkinson's disease care in the Philippines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Epidemiology of Parkinson's Disease-East Versus West

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Development of a Thai Parkinson's Disease Screening Tool and the Prevalence of Parkinsonism and Parkinson's Disease, Based on a Community Survey in Bangkok

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Parkinson's disease across ethnicities: A nationwide study in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Systematic review of the prevalence and incidence of Parkinson's disease in the People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prevalence of Parkinson's disease across North America.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The prevalence of Parkinson's disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The epidemiology of Parkinson's disease: risk factors and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The future burden of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Disparities in meeting physical activity guidelines for Asian-Americans in two metropolitan areas in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Diabetes in Asia and the Pacific: Implications for the Global Epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Parkinson's disease and the gastrointestinal microbiome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Chronic obstructive pulmonary disease in China: a nationwide prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Parkinson's disease research in a prospective cohort in China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Genetics of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Will genotype drive treatment options?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Progression in the LRRK2-Asssociated Parkinson Disease Population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Glucocerebrosidase gene mutations associated with Parkinson's disease: a meta-analysis in a Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Patterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Crystal structure of the WD40 domain dimer of LRRK2

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

1 reference

7 January 2021

Levodopa: A new look at an old friend

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Helicobacter pylori infection is associated with worse severity of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The impact of non-motor symptoms on the Health-Related Quality of Life of Parkinson's disease patients from Southwest China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Non-motor symptoms of Parkinson's disease in China: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Longitudinal analysis of impulse control disorders in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prevalence of restless legs syndrome in Parkinson's disease: a systematic review and meta-analysis of observational studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prodromal Parkinson's Disease: The Decade Past, the Decade to Come

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Phenoconversion from Idiopathic Rapid Eye Movement Sleep Behavior Disorder to Lewy Body Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

REM sleep behavior disorder in Japanese patients with Parkinson's disease: a multicenter study using the REM sleep behavior disorder screening questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Knowledge of Parkinson's Disease in a Multiethnic Urban Asian Setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Identifying gaps in knowledge about Parkinson disease among medical professionals in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Integrating Patient Concerns into Parkinson's Disease Management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Patient perspectives on Parkinson's disease therapy in Japan and the United States: results of two patient surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Levodopa and Parkinson Disease-Myths Revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Deep Brain Stimulation for Parkinson Disease in the Philippines: Outcomes of the Philippine Movement Disorder Surgery Center.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease in Hong Kong: A Prospective Territory-Wide 2-Year Follow-Up Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prognostic factors for early mortality in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Pimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

How close are we to individualized medicine for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

What matters to people with Parkinson's disease living in Australia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Medical and surgical management of advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Patients' reluctance to undergo deep brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Deep brain stimulation for Parkinson disease in Australia: current scientific and clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Interdisciplinary teamwork for the treatment of people with Parkinson's disease and their families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Neuroendocrine abnormalities in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Prevalent cerebrovascular and cardiovascular disease in people with Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Osteoporosis in East Asia: Current issues in assessment and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Diabetes is associated with postural instability and gait difficulty in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Can therapeutic Thai massage improve upper limb muscle strength in Parkinson's disease? An objective randomized-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Translational potential of human brain organoids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2819%2930195-4

7 January 2021

10.1016/S1474-4422(19)30195-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31175000%20AND%20SRC:MED&resulttype=core&format=json